Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis: Complete Statistical AnalysisIndependent statistical analysis of Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02886936).
- Immediate Loading and Fully Guided Surgery: Single Implants: Complete Statistical AnalysisIndependent statistical analysis of Immediate Loading and Fully Guided Surgery: Single Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061694).
- Immediate Loading Of Dental Implants: A Pilot Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Immediate Loading Of Dental Implants: A Pilot Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01644058).
- Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Immediate Postmastectomy Breast Reconstruction (Strattice Breast): Complete Statistical AnalysisIndependent statistical analysis of Immediate Postmastectomy Breast Reconstruction (Strattice Breast): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00619762).
- Immediate Postplacental IUD Insertion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Postplacental IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02169869).
- Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis: primary endpoint results, effect estimate…
- Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation: Complete Statistical AnalysisIndependent statistical analysis of Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immediate-Release Oxycodone Capsules Study in Cancer Pain: Complete Statistical AnalysisIndependent statistical analysis of Immediate-Release Oxycodone Capsules Study in Cancer Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01675622).
- Immersive Virtual Reality and Chronic Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality and Chronic Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04307446).
- Immersive Virtual Reality Bicycling for Persons With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05160025).
- Immersive Virtual Reality Exposure for Reducing Preoperative Anxiety in Children: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Exposure for Reducing Preoperative Anxiety in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07018999).
- Immersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IMmotion151Independent statistical analysis of A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size…
- IMMULAB – Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers: Complete Statistical AnalysisIndependent statistical analysis of Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03278626).
- Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants: Complete Statistical AnalysisIndependent statistical analysis of Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial): Complete Statistical AnalysisIndependent statistical analysis of Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease: Complete Statistical AnalysisIndependent statistical analysis of Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1): Complete Statistical AnalysisIndependent statistical analysis of Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immune Response Following Seasonal Influenza Vaccination: Complete Statistical AnalysisIndependent statistical analysis of Immune Response Following Seasonal Influenza Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03163342).
- Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings: Complete Statistical AnalysisIndependent statistical analysis of Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease: Complete Statistical AnalysisIndependent statistical analysis of Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immune Responses Induced by Different Licensed Influenza Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Immune Responses Induced by Different Licensed Influenza Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902278).
- Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant: Complete Statistical AnalysisIndependent statistical analysis of Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578317).
- Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects: Complete Statistical AnalysisIndependent statistical analysis of Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00706550).
- Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10: Complete Statistical AnalysisIndependent statistical analysis of Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunization To Prevent Acute COPD Exacerbations: Complete Statistical AnalysisIndependent statistical analysis of Immunization To Prevent Acute COPD Exacerbations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03276754).
- Immuno & Safety Study of GSK Biologicals’ Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs: Complete Statistical AnalysisIndependent statistical analysis of Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs: primary endpoint results, effect estimate with confidence interval, sample-size…
- Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients: Complete Statistical AnalysisIndependent statistical analysis of Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immuno-nutrition Supplementation in Haemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Immuno-nutrition Supplementation in Haemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05700851).
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunogenicity & Safety of GSK’s Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals’ Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above: primary endpoint…
- Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety of a Purified Vero Rabies Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of a Purified Vero Rabies Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03145766).
- Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060): Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060): primary endpoint results, effect…
- Immunogenicity and Safety of GlaxoSmithKline Biologicals’ Infanrix™-IPV+Hib Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01309646).
- Immunogenicity and Safety of GSK Biologicals’ Infanrix/Hib in Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00696423).